A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays.

The drug molecule PTC124 (Ataluren) has been described as a read-through agent, capable of suppressing premature termination codons (PTCs) and restoring functional protein production from genes disrupted by nonsense mutations. Following the discovery of PTC124 there was some controversy regarding it...

Full description

Saved in:
Bibliographic Details
Main Authors: Stuart P McElroy, Toshifumi Nomura, Leah S Torrie, Emma Warbrick, Ulrike Gartner, Gavin Wood, W H Irwin McLean
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS Biology
Online Access:https://doi.org/10.1371/journal.pbio.1001593
Tags: Add Tag
No Tags, Be the first to tag this record!